| Completed | 2 | 82 | Europe, US, RoW | LUM-201, rhGH Norditropin® pen (34 µg/kg) | Lumos Pharma, Lumos Pharma | Growth Hormone Deficiency | 09/24 | 09/24 | | |
| Completed | 3 | 4800 | Europe, Canada, US, RoW | Placebo (0.9% saline), normal saline; NaCl 0.9%, Pantoprazole, Protonix | McMaster University, Canadian Institutes of Health Research (CIHR), Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group, National Health and Medical Research Council, Australia | Gastrointestinal Hemorrhage (Clinically Important, Upper) | 10/23 | 01/24 | | |
ACTRN12616001683426: Correlation of peripheral venous collapse with central venous pressure as a non-invasive bedside clinical sign |
|
|
| Not yet recruiting | N/A | 86 | | | Epworth Healthcare, Epworth Healthcare | Correlation between peripheral venous collapse and central venous pressure | | | | |
ACTRN12620001193965: The adequacy of user seal checking for N95 respirators compared to formal fit testing, a multicentred observational study |
|
|
| Recruiting | N/A | 150 | | | Epworth HealthCare, Epworth HealthCare | Protection from airborne pathogens, COVID-19 | | | | |
